
Helex, US head-quartered, uses CRISPR technology to enable safer gene editing, which provides a workable therapy to millions of people suffering from rare genetic disorders that have so far have no cure. I'll be talking to Rohini Kalvakuntla, co-founder of the company. It was founded in 2021, is hq-ed in NewYork. ( Indian Founders.). Helex was one of the only Indian companies part of IndieBio- world's largest biotech accelerator backed by SOSV. It is is a partner from lab to commercialization, ultimately helping therapeutic companies fasten their time to market.
Frequently Asked Questions